Literature DB >> 27477408

Hyperthyroidism Improves the Pathological Condition of Nonalcoholic Steatohepatitis: A Case of Nonalcoholic Steatohepatitis with Graves' Disease.

Teruki Miyake1, Bunzo Matsuura, Shinya Furukawa, Yasuhiko Todo, Shin Yamamoto, Osamu Yoshida, Yusuke Imai, Takao Watanabe, Yasunori Yamamoto, Masashi Hirooka, Yoshio Tokumoto, Teru Kumagi, Masanori Abe, Hirotaka Seike, Shozo Miyauchi, Yoichi Hiasa.   

Abstract

3,5,3'-triiodo-L-thyronine regulates the glucose metabolism, lipid metabolism, and hepatic steatosis. Several groups have shown the relationships between hypothyroidism and nonalcoholic fatty liver and hypothyroidism and nonalcoholic steatohepatitis (NASH). However, the effect of hyperthyroidism on NASH has not yet been investigated. We herein report effects of thyroid hormone on the pathological condition of NASH in a patient with NASH complicated by Graves' disease. In our case, the liver enzyme level improved with the increasing thyroid hormone level; however, the liver enzyme level was aggravated with the improving thyroid hormone level. Therefore, hyperthyroidism may improve the pathological condition of NASH.

Entities:  

Mesh:

Year:  2016        PMID: 27477408     DOI: 10.2169/internalmedicine.55.6640

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

Review 1.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

Review 2.  Unraveling the Role of Hypothyroidism in Non-alcoholic Fatty Liver Disease Pathogenesis: Correlations, Conflicts, and the Current Stand.

Authors:  Rajvi Gor; Nabeel A Siddiqui; Ransirini Wijeratne Fernando; Archana Sreekantan Nair; Janan Illango; Mushrin Malik; Pousette Hamid
Journal:  Cureus       Date:  2021-05-05

Review 3.  Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Ecaterina Neculae; Claudia Florida Costea; Manuela Ciocoiu; Loredana Liliana Hurjui; Claudia Cristina Tarniceriu; Mariana Floria
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

4.  Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients.

Authors:  Bairong Wang; Baomin Wang; Yumei Yang; Jing Xu; Mengyang Hong; Mingfeng Xia; Xiaomu Li; Xin Gao
Journal:  BMC Endocr Disord       Date:  2021-02-18       Impact factor: 2.763

Review 5.  Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review.

Authors:  Madalena Von-Hafe; Marta Borges-Canha; Catarina Vale; Ana Rita Leite; João Sérgio Neves; Davide Carvalho; Adelino Leite-Moreira
Journal:  Metabolites       Date:  2022-03-29

Review 6.  Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease.

Authors:  Eleonore Fröhlich; Richard Wahl
Journal:  Metabolites       Date:  2022-08-04

Review 7.  Thyroid Hormones, Thyromimetics and Their Metabolites in the Treatment of Liver Disease.

Authors:  Marta A Kowalik; Amedeo Columbano; Andrea Perra
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-10       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.